Koninklijke Philips N.V. operates as a health technology company worldwide.
Established dividend payer and good value.
Share Price & News
How has Koninklijke Philips's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: PHG has not had significant price volatility in the past 3 months.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: PHG exceeded the US Medical Equipment industry which returned 21.9% over the past year.
Return vs Market: PHG exceeded the US Market which returned 20.3% over the past year.
Price Volatility Vs. Market
How volatile is Koninklijke Philips's share price compared to the market and industry in the last 5 years?
Simply Wall St News
2 years ago | Simply Wall StIs Koninklijke Philips NV (PHG) a good choice for dividend investors?
2 years ago | Simply Wall StCould Koninklijke Philips NV (PHG) be actually undervalued when we account for its future growth?
Is Koninklijke Philips undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: PHG ($48.61) is trading below our estimate of fair value ($66.35)
Significantly Below Fair Value: PHG is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: PHG is good value based on its PE Ratio (34.3x) compared to the Medical Equipment industry average (47.5x).
PE vs Market: PHG is poor value based on its PE Ratio (34.3x) compared to the US market (18.3x).
Price to Earnings Growth Ratio
PEG Ratio: PHG is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: PHG is good value based on its PB Ratio (3.2x) compared to the US Medical Equipment industry average (4.1x).
How is Koninklijke Philips forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: PHG's forecast earnings growth (15.7% per year) is above the savings rate (1.7%).
Earnings vs Market: PHG's earnings (15.7% per year) are forecast to grow faster than the US market (14.2% per year).
High Growth Earnings: PHG's earnings are forecast to grow, but not significantly.
Revenue vs Market: PHG's revenue (4.8% per year) is forecast to grow slower than the US market (7.6% per year).
High Growth Revenue: PHG's revenue (4.8% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: PHG's Return on Equity is forecast to be low in 3 years time (14.6%).
How has Koninklijke Philips performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: PHG has high quality earnings.
Growing Profit Margin: PHG's current net profit margins (6.1%) are lower than last year (7.2%).
Past Earnings Growth Analysis
Earnings Trend: PHG's earnings have grown significantly by 33.9% per year over the past 5 years.
Accelerating Growth: PHG's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: PHG had negative earnings growth (-9%) over the past year, making it difficult to compare to the Medical Equipment industry average (7.1%).
Return on Equity
High ROE: PHG's Return on Equity (9.4%) is considered low.
Return on Assets
Return on Capital Employed
How is Koninklijke Philips's financial position?
Financial Position Analysis
Short Term Liabilities: PHG's short term assets (€9.4B) exceed its short term liabilities (€6.9B).
Long Term Liabilities: PHG's short term assets (€9.4B) exceed its long term liabilities (€7.4B).
Debt to Equity History and Analysis
Debt Level: PHG's debt to equity ratio (40.5%) is considered high.
Reducing Debt: PHG's debt to equity ratio has increased from 35.8% to 40.5% over the past 5 years.
Debt Coverage: PHG's debt is well covered by operating cash flow (39.2%).
Interest Coverage: PHG's interest payments on its debt are well covered by EBIT (14.2x coverage).
Inventory Level: PHG has a high level of physical assets or inventory.
Debt Coverage by Assets: PHG's debt is covered by short term assets (assets are 1.8x debt).
What is Koninklijke Philips's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Purchase Koninklijke Philips before the 'Buy Limit' to receive their next dividend payment.
Dividend Yield vs Market
Current dividend yield vs market & industry
Notable Dividend: PHG's dividend (1.89%) is higher than the bottom 25% of dividend payers in the US market (1.44%).
High Dividend: PHG's dividend (1.89%) is low compared to the top 25% of dividend payers in the US market (3.73%).
Stability and Growth of Payments
Stable Dividend: PHG's dividends per share have been stable in the past 10 years.
Growing Dividend: PHG's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonable payout ratio (64.7%), PHG's dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: PHG's dividends in 3 years are forecast to be well covered by earnings (38.9% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Frans van Houten (59yo)
Mr. François Adrianus van Houten, also known as Frans, has been the Chief Executive Officer and Chairman of Management Board of Royal Philips at Philips India Limited since April 2011. Mr. van Houten serve ...
CEO Compensation Analysis
Compensation vs Market: Frans's total compensation ($USD5.82M) is below average for companies of similar size in the US market ($USD10.78M).
Compensation vs Earnings: Frans's compensation has been consistent with company performance over the past year.
|Chairman of the Board of Management & CEO||8.8yrs||€5.39m||0.039% €16.9m|
|Vice-Chairwoman of the Supervisory Board & Secretary||0yrs||€154.88k||no data|
|Executive VP||4.3yrs||€2.60m||0.010% €4.4m|
|Executive VP||2.3yrs||€1.86m||0.0077% €3.4m|
|Executive VP & Chief of Operations||3.4yrs||no data||no data|
|Head of Investor Relations||0.5yrs||no data||no data|
|Chief Human Resources Officer||0.08yrs||no data||no data|
|Chief Design Officer||8.3yrs||no data||no data|
|Executive VP & Chief Business Leader of Connected Care Business||1.3yrs||no data||no data|
|Executive VP and Chief Innovation & Strategy Officer||3.6yrs||no data||no data|
Experienced Management: PHG's management team is considered experienced (3.4 years average tenure).
|Vice-Chairwoman of the Supervisory Board & Secretary||0yrs||€154.88k||no data|
|Member of Supervisory Board||5.8yrs||€121.25k||no data|
|Member of Supervisory Board||4.8yrs||€142.25k||no data|
|Chairman of the Supervisory Board||8.9yrs||€179.50k||0.0021% €891.9k|
|Member of Supervisory Board||1.5yrs||€46.67k||no data|
|Member of Supervisory Board||7.8yrs||€123.75k||no data|
|Member of Supervisory Board||1.3yrs||€42.33k||no data|
|Member of Supervisory Board||0.8yrs||no data||no data|
Experienced Board: PHG's board of directors are considered experienced (4.8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Koninklijke Philips N.V.'s company bio, employee growth, exchange listings and data sources
- Name: Koninklijke Philips N.V.
- Ticker: PHG
- Exchange: NYSE
- Founded: 1891
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: €40.105b
- Listing Market Cap: €43.296b
- Shares outstanding: 889.54m
- Website: https://www.philips.com
Number of Employees
- Koninklijke Philips N.V.
- Philips Center
- Amstelplein 2
- 1096 BC
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|PHG||NYSE (New York Stock Exchange)||NY REG SH NEW||US||USD||Jan 1980|
|PHIA||DB (Deutsche Boerse AG)||NY REG SH NEW||DE||EUR||Jan 1980|
|PHIA||XTRA (XETRA Trading Platform)||NY REG SH NEW||DE||EUR||Jan 1980|
|0A2M||LSE (London Stock Exchange)||NY REG SH NEW||GB||USD||Jan 1980|
|RYLP.F||OTCPK (Pink Sheets LLC)||Yes||Common Shares||US||USD||Dec 1980|
|PHI1||DB (Deutsche Boerse AG)||Yes||Common Shares||DE||EUR||Dec 1980|
|PHI||SWX (SIX Swiss Exchange)||Yes||Common Shares||CH||CHF||Dec 1980|
|PHIA||ENXTAM (Euronext Amsterdam)||Yes||Common Shares||NL||EUR||Dec 1980|
|PHIA||BIT (Borsa Italiana)||Yes||Common Shares||IT||EUR||Dec 1980|
|PHI1||XTRA (XETRA Trading Platform)||Yes||Common Shares||DE||EUR||Dec 1980|
|0LNG||LSE (London Stock Exchange)||Yes||Common Shares||GB||EUR||Dec 1980|
|PHIAA||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Common Shares||GB||EUR||Dec 1980|
|PHIA||WBAG (Wiener Boerse AG)||Yes||Common Shares||AT||EUR||Dec 1980|
|PHIA N||BMV (Bolsa Mexicana de Valores)||Yes||Common Shares||MX||MXN||Dec 1980|
Koninklijke Philips N.V. operates as a health technology company worldwide. It operates through Diagnosis & Treatment, Connected Care & Health Informatics, and Personal Health segments. The company offers mother, child care, and oral healthcare products; male grooming and beauty products; food preparation and home care products; and sleep and respiratory care. It provides diagnostic X-ray, integrated clinical, magnetic resonance imaging, computed tomography, and molecular imaging solutions. The company also offers interventional X-ray systems, and imaging and therapy devices for treatment of coronary artery and peripheral vascular disease; imaging products focus on diagnosis, treatment planning, and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; and proprietary software to enable diagnostics and intervention. Further, it provides patient monitoring solutions; patient analytics, precision diagnosis, and clinical decision support systems; therapeutic care products; patient monitoring and therapeutic care consumables; and customer services. Additionally, the company offers healthcare information technology, clinical, and visualization and quantification informatics solutions for radiology, cardiology, and oncology departments; universal data management solutions, picture archiving and communication systems, and integrated electronic medical record systems; clinical and hospital IT platforms; technology-enabled monitoring and intervention, actionable program, cloud-based, and population health management software solutions. It also provides digital frameworks that connect consumers, patients, and healthcare providers in a cloud-based connected health ecosystem of devices, apps, and tools. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/02/20 00:15|
|End of Day Share Price||2020/02/19 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.